Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MPS-Venture is a biotechnology company based in Berlin, Germany, specializing in the development and strategic implementation of Microphysiological Systems (MPS), also known as Organ-on-a-Chip technology. Founded by Dr. Uwe Marx, a pioneer in the field, the company focuses on Multi-Organ-Chip (MOC) platforms that simulate human physiology and organ-organ interactions in a microfluidic environment. MPS-Venture provides consultancy, R&D services, and intellectual property management to support the pharmaceutical, chemical, and cosmetic industries in adopting more predictive, human-relevant alternatives to animal testing. By integrating multiple organ equivalents on a single chip, the company's technology enables advanced studies in drug toxicity, pharmacokinetics, and disease modeling. MPS-Venture plays a central role in the global MPS community, frequently collaborating with academic institutions and commercial partners to advance the standardization and regulatory acceptance of these technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MPS Venture.